A young woman with advanced, inoperable tongue cancer experienced a rare recovery after immunotherapy and chemotherapy.

Cardiac toxicities such as myocarditis are rare but carry a high risk of being fatal. The data emphasize that the most ...

CLEVELAND, Ohio —Bacteria inside cancerous tumors may be a key reason why immunotherapy works for some patients but not others, researchers from the Cleveland Clinic and other institutes have ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

A New Jersey veteran diagnosed with an aggressive cancer has surprised his own doctors, and now his case could give hope to other patients. In December 2024, at age 97, Mountainside resident Teddy ...

A new UCLA investigator-initiated study has found that adding immunotherapy to standard chemotherapy before surgery is safe and shows promise for some patients with borderline-resectable pancreatic ...

Cancer immunotherapy has been a game-changer, but many tumors still find ways to slip past the immune system. New research reveals a hidden trick: cancer cells can package the immune-blocking protein ...

Optimal surgical debulking to R0 remains a dominant prognostic determinant in ovarian cancer, while PARP inhibitor maintenance has become integral for BRCA-mutant and HRD-positive tumors.

DOCTOR, SEVERAL NEW TREATMENTS ARE REVOLUTIONIZING THE FIGHT AGAINST BREAST CANCER AND CHIEF OF MEDICAL ONCOLOGY AT MERCY MEDICAL CENTER, DOCTOR DAVID REISBERG IS JOINING US NOW WITH SOME MORE ...

A research team led by the Department of Clinical Oncology, Center of Cancer Medicine, School of Clinical Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has identified a ...

Cancer treatment has changed dramatically over the past decade. What was once dominated by extensive surgeries followed by aggressive chemotherapy and radiation has now evolved into a more balanced, ...